Market Expertise
Market Access Consulting Company for efficient healthcare patient healthcare access
An international team with local experience in Switzerland , European Union AND Latin America defining strategic excellence for global healthcare markets
Market Access Consulting Company for efficient healthcare patient healthcare access
An international team with local experience in Switzerland, EU, LA defining
strategic excellence for global healthcare markets
Start Your Journeystrategic excellence for global healthcare markets
Your Trusted Advisors in Business Success.
As an experienced Market Access Consulting Company healthcare success depends on evidence beyond clinical results. It requires a strong understanding of the clinical, socio-economic value added of the value proposition as well as the pricing & reimbursement stakeholders expectations and perceptions.
We partner with well established experts for strategy development and implementation to find innovative market access solutions for efficient market entry agreements.To assure market access success we focus on simple innovative solutions to ensure that the value proposition is well understood by patients, healthcare deciders and providers in a coherent way.
0+
Statisfied Customers
0+
Years Experience
0+
Projects Completed
Our Mantra
As a preferred approach by a Market Access Consulting Company
Real outcomes from real buildings — backed by data and engineering accountability.
Assessment and Strategy
Assessment of local, regional, and international factors, including KSFs, policies, and strategy development guided by a Healthcare Market Access Consultant.
Implementation
Price finding, health-economic evidence, and negotiation strategy with hands-on support from a Market Access Consulting Company.
Advocacy
Value communication, advocacy, and negotiation training designed by a Healthcare Market Access Consultant to strengthen stakeholder engagement.
Shaping
Monitoring impact, exploring joint value maximization projects, and supporting long-term healthcare system outcomes through expert market access guidance.
Why Choose Us?
Choosing the right partner in healthcare market access and strategy can significantly influence the success of your product. We combine deep expertise in health economics, pricing, and reimbursement with a practical, results-driven approach.
Our team brings decades of international experience and a strong understanding of payer expectations. We focus on delivering clear, evidence-based strategies that help you achieve faster, more effective market access while maximizing product value across diverse healthcare systems.
Jorge Wernli
Dipl Ing ETH/MBA IMD
Peter Braunhofer
MSc. Biol, CAS Pharm-Med,MHBA
Dr. med. Lorraine Zakin
RWE studies support
WHP networked team
Members of the Board
Jorge Wernli (Founder), CEO WHPManagement Consulting
Dr. Peter Lauper (Founder), Ex Worldwide Vice President Johnson & Johnson, Senior Advisor
Jorge Wernli (Founder), CEO WHPManagement Consulting
Dr. Peter Lauper (Founder), Ex Worldwide Vice President Johnson & Johnson, Senior Advisor
Academia Alliance Network
Prof. Felix Gutzwiller, University of Zürich, Swiss Federal Parliament
Prof. Lorenzo Mantovani, Universita Bocconi, Milano, Napoli
Prof. Bengt Joensson, Stockholm School of Economics (SSE)
Prof. Gerard de Pouvourville, Ecole Sep de Science Economicques et Commerciales (ESSEC)
Dr. Panos Kanavos, Inl Health Policy Development, Social Policies, LSE
Prof. Dr. Walter P. von Wartburg, Law & Life Sciences
Prof. Felix Gutzwiller, University of Zürich, Swiss Federal Parliament
Prof. Lorenzo Mantovani, Universita Bocconi, Milano, Napoli
Prof. Bengt Joensson, Stockholm School of Economics (SSE)
Prof. Gerard de Pouvourville, Ecole Sep de Science Economicques et Commerciales (ESSEC)
Dr. Panos Kanavos, Inl Health Policy Development, Social Policies, LSE
Prof. Dr. Walter P. von Wartburg, Law & Life Sciences
Strategic Alliances
Dr. Francesco Conti, President Fondazione Charta, Milano, Italy
Jorge Felix, Managing Partner, EXIGO, Lisboa, Portugal
Dr. Lamine Mahi, Axelys Santé, Paris, France
Justin Stindt Consulting, JSC, Paris, France, Germany Academia
Dr. Timm Volmer, MPH, SmartStep Consulting GmbH Healthcare Strategy & Market Access Consulting
Consulting /Advisory Network/Foundations Network
Mark Gordon, Vantage Partners, Boston, USA
Takis Zervakakis, Chief Executive Officer ILS Consulting, Innovation in Life Sciences
Patrick Johnson PhD, Consulting M&S Statistician, JPharma Solutions GmbH, Switzerland
Eva Kalias, MS Biochemistry University of Zuerich, MBA IMD Communication, VioConsult, Zuerich Jenny Dietschweiler, Personal Trainer, Paramedic Bülach, St.Gallen Switzerland
Dr. Carine Abt, Health4U, Switzerland Daniel T. Kessler, Governance, Risk Management & Compliance Lawyer, Givon Advisors Ltd/ITR Compliance Group
Joe Henein, NB Pharma, Dubai, UAE
David Danko, Ideas & Solutions Consulting and Research Leader Corvinius University Budapest, Hungary
Dr. Harlald Rinde, BioBridge Strategies, Halteres Associates, LLC, California, San Diego, Binningen
Klaas Duijn, Health Care Consultancy, The Netherlands, Market access ,strategy & negotiations, coaching
Christian Huyghe, Healthcare Sector Entrepreneur, Brussels, Belgium
Dr. Francesco Conti, President Fondazione Charta, Milano, Italy
Jorge Felix, Managing Partner, EXIGO, Lisboa, Portugal
Dr. Lamine Mahi, Axelys Santé, Paris, France
Justin Stindt Consulting, JSC, Paris, France, Germany Academia
Dr. Timm Volmer, MPH, SmartStep Consulting GmbH Healthcare Strategy & Market Access Consulting
Consulting /Advisory Network/Foundations Network
Mark Gordon, Vantage Partners, Boston, USA
Takis Zervakakis, Chief Executive Officer ILS Consulting, Innovation in Life Sciences
Patrick Johnson PhD, Consulting M&S Statistician, JPharma Solutions GmbH, Switzerland
Eva Kalias, MS Biochemistry University of Zuerich, MBA IMD Communication, VioConsult, Zuerich Jenny Dietschweiler, Personal Trainer, Paramedic Bülach, St.Gallen Switzerland
Dr. Carine Abt, Health4U, Switzerland Daniel T. Kessler, Governance, Risk Management & Compliance Lawyer, Givon Advisors Ltd/ITR Compliance Group
Joe Henein, NB Pharma, Dubai, UAE
David Danko, Ideas & Solutions Consulting and Research Leader Corvinius University Budapest, Hungary
Dr. Harlald Rinde, BioBridge Strategies, Halteres Associates, LLC, California, San Diego, Binningen
Klaas Duijn, Health Care Consultancy, The Netherlands, Market access ,strategy & negotiations, coaching
Christian Huyghe, Healthcare Sector Entrepreneur, Brussels, Belgium
Frequently Asked Questions
What services does WH Partners provide?
WH Partners delivers strategic management consulting with a focus on healthcare and pharmaceutical industries. Services typically include Market Access strategic advice, Pricing and Reimbursement Consultant support, commercialization planning, and business optimization.
Which industries do you specialize in
We primarily work with pharmaceutical companies, biotech firms, healthcare organizations, and life sciences businesses seeking strategic growth, regulatory alignment, and improved market positioning.
Do you support market access and pricing strategy?
Yes. Our team provides Market Access strategic advice and guidance as Pricing and Reimbursement Consultants, helping clients develop evidence-based pricing models, Pricing and reimbursement BAG strategies, and value propositions aligned with Swiss and international healthcare systems.
Do you work with international clients?
Absolutely. While based in Switzerland, we support both local and international organizations navigating European healthcare markets, pricing, reimbursement regulations, and strategic market access planning.
How do you tailor your consulting approach?
Every engagement is customized. We analyze your business objectives, competitive landscape, and regulatory environment to design practical, data-driven strategies, including Market Access strategic advice and Pricing and Reimbursement Consultant insights.
Can you help with product launch planning?
Yes. We support end-to-end launch strategies, including stakeholder mapping, value communication, Pricing and reimbursement BAG guidance, and market entry planning to maximize adoption.
What makes WH Partners different from larger consulting firms?
We are small, fast and flexible, with practical experience in well known pharmaceutical companies and start-ups as well as health insurance companies over decades.
How can we start working together?
You can contact us through our website’s contact form or schedule an initial consultation. We begin with a discussion to understand your goals and determine how we can best support your strategic objectives, including Market Access strategic advice and Pricing and reimbursement BAG strategies.
Schedule
A Call.
Why Choose Us?
Trusted by 500+ satisfied customers with over 10+ years of experience in global healthcare markets.
Get in Touch
Fill out the form below and our team will get back
Schedule A Call.
Why Choose Us?
Trusted by 500+ satisfied customers with over 10+ years of experience in global healthcare markets.
Get in Touch
Fill out the form below and our team will get back to you shortly.